We are a research group investigating Alzheimer's disease (AD) and other dementias. We use neuroimaging procedures, such as PET and MRI, to understand how the brain is changed in dementia. We also test memory and other thinking skills, and interview our patients to understand what types of emotional problems they are having (such as depression or irritability). We combine all of this information to help us understand the symptoms of dementia and the brain changes that contribute to the illness.
Our lab is also involved in treatment studies. In these experiments, we prescribe medication(s), and then test patients to understand how the drug is helping. We are conducting clinical trials both for FDA approved medications and for a new investigational drug to treat AD.
Director: David Sultzer